SLC2A1 and neoplasm: The persistence of markers such as GLUT1, CD57, PD-1, KLRG1, and soluble TIM-3/Gal-9, along with altered protease profiles, suggests a chronic immunosuppressive microenvironment that may impair tumor surveillance and immune resilience.